We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MACK market cap is 218.18M. The company's latest EPS is USD -0.0814 and P/E is -184.64.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 139k | 0 | 0 |
Operating Income | -504k | -607k | -447k | -569k | -531k |
Net Income | -442k | -492k | -271k | -391k | -279k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -27.27M | -5.01M | -2.62M | -2.17M | -2.18M |
Net Income | -17.33M | -3.03M | -2.46M | -1.54M | -1.18M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 13.64M | 19.84M | 19.64M | 19.45M | 19.3M |
Total Liabilities | 448k | 589k | 463k | 411k | 493k |
Total Equity | 13.19M | 19.25M | 19.17M | 19.04M | 18.81M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 20.08M | 16.78M | 14.75M | 19.84M | 19.19M |
Total Liabilities | 2.77M | 770k | 562k | 589k | 441k |
Total Equity | 17.31M | 16.01M | 14.19M | 19.25M | 18.75M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -1.56M | -1.74M | -356k | -1.02M | -1.23M |
Investing | 445k | 445k | 139k | -8.67M | -12.52M |
Financing | N/A | 6.53M | 179k | 388k | 388k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -31.37M | -4.63M | -218k | -1.74M | -1.52M |
Investing | 69.83M | 2.14M | 144k | 445k | -12.45M |
Financing | -42.54M | -56k | 239k | 6.53M | 521k |
Market Cap | 218.18M |
Price to Earnings Ratio | -184.64 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 36.43 |
Price to Book Ratio | 11.64 |
Dividend Yield | - |
Shares Outstanding | 14.52M |
Average Volume (1 week) | 128.02k |
Average Volume (1 Month) | 107.18k |
52 Week Change | 19.19% |
52 Week High | 15.89 |
52 Week Low | 11.53 |
Spread (Intraday) | 0.04 (0.27%) |
Company Name | Merrimack Pharmaceuticals Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.merrimack.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions